Hainan Honz Pharmaceutical Co Cash Flow-to-Debt Ratio
Hainan Honz Pharmaceutical Co cash flow-to-debt ratio. Hainan Honz Pharmaceutical Co (300086) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-9.17 Million could theoretically repay 0% of its total liabilities (CN¥805.18 Million) in one year. Check Hainan Honz Pharmaceutical Co earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hainan Honz Pharmaceutical Co (2007–2025)
Cash flow-to-debt ratio of Hainan Honz Pharmaceutical Co from 2007 to 2025. Historical debt coverage capacity for Hainan Honz Pharmaceutical Co across 19 annual periods. Check 300086 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Hainan Honz Pharmaceutical Co Cash Flow-to-Debt Ratio by Year (2007–2025)
Hainan Honz Pharmaceutical Co cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Hainan Honz Pharmaceutical Co. For the full cash flow conversion analysis, see Hainan Honz Pharmaceutical Co cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | CN¥121.24 Million | CN¥869.79 Million | ▲ +58.1% |
| 2024 | 0.09x | CN¥71.46 Million | CN¥810.53 Million | ▼ -1.8% |
| 2023 | 0.09x | CN¥70.69 Million | CN¥787.60 Million | ▲ +185.6% |
| 2022 | 0.03x | CN¥29.32 Million | CN¥932.96 Million | ▲ +151.1% |
| 2021 | 0.01x | CN¥11.33 Million | CN¥905.14 Million | ▲ +175.6% |
| 2020 | -0.02x | CN¥-16.74 Million | CN¥1.01 Billion | ▼ -121.8% |
| 2019 | 0.08x | CN¥45.06 Million | CN¥592.59 Million | ▼ -74.6% |
| 2018 | 0.30x | CN¥157.66 Million | CN¥526.90 Million | ▲ +419.2% |
| 2017 | 0.06x | CN¥18.17 Million | CN¥315.31 Million | ▼ -79.9% |
| 2016 | 0.29x | CN¥90.88 Million | CN¥316.83 Million | ▼ -9.0% |
| 2015 | 0.32x | CN¥78.30 Million | CN¥248.25 Million | ▼ -47.7% |
| 2014 | 0.60x | CN¥73.93 Million | CN¥122.49 Million | ▼ -27.8% |
| 2013 | 0.84x | CN¥78.93 Million | CN¥94.36 Million | ▼ -27.4% |
| 2012 | 1.15x | CN¥109.46 Million | CN¥95.02 Million | ▲ +226.4% |
| 2011 | -0.91x | CN¥-100.94 Million | CN¥110.77 Million | ▼ -186.7% |
| 2010 | 1.05x | CN¥79.89 Million | CN¥76.01 Million | ▼ -39.8% |
| 2009 | 1.75x | CN¥93.58 Million | CN¥53.60 Million | ▲ +56.0% |
| 2008 | 1.12x | CN¥62.61 Million | CN¥55.93 Million | ▼ -6.0% |
| 2007 | 1.19x | CN¥30.59 Million | CN¥25.68 Million | — |